close
close

Antidepressant Recall: The FDA upgrades the drug risk class to the second highest level in the recall update

The US Food and Drug Administration has recalled thousands of bottles of antidepressants because the drugs contained high levels of a cancer-causing chemical. Now the FDA is assigning the second highest risk level to the recall of duloxetine extended-release capsules manufactured by Towa Pharmaceutical Europe. The capsules have been classified as a Class II recall, […]

Antidepressant recalled: second highest FDA risk level; The drug contains cancer-causing chemicals

According to the FDA, thousands of bottles of antidepressants are being recalled because they contain high levels of cancer-causing chemicals. The FDA assigned the drug duloxetine extended-release capsules to the second-highest risk level after drug distributor Breckenridge Pharmaceutical Inc. voluntarily issued the recall earlier this month. A Class II recall represents “a situation in which […]